Molecular diagnosis of Huntington's disease in Costa Rica
DOI:
https://doi.org/10.51481/amc.v50i1.350Keywords:
Costa Rica, molecular diagnosis, Huntington disease, genetic instability, instable mutations, CAG repeat tripletsAbstract
Justification and Aim. This study represents an effort to establish the molecular diagnosis of Huntington's disease in Costa Rica. This would improve the clinical management of the patients and that could be translated into better quality of life for them and their families. Aim: to determine the number of CAG repeats in affected individuals and their relatives by molecular diagnosis in order to offer them adequate genetic counseling.
Methods: The study involved 7 patients with clinical diagnosis of this disease and 31 relatives at risk. To determine the number of repeats we used the polymerase chain reaction and electrophoresis on agarose and polyacrylamide gels.
Results: We obtained the molecular diagnosis in all of the individuals. The clinical diagnosis was confirmed in the 7 affected individuals, 11 remained asymptomatic but carrying the mutation and 20 were found without the mutation. A negative correlation was observed between the age of onset and the repeat size. We also observed intergenerational instability, both through the maternal and paternal side. There were no differences in the number of repeats according to sex of the progenitor transmitter.
Conclusions: Our molecular analyses showed a profile of repeats similar to other populations. We have identified for the first time families carrying a CAG expansion in Costa Rica, which will allow us to give adequate and opportune genetic counseling to the patients and their families, based on reliable information.
Downloads
References
Harper PS. The epidemiology of Huntington's disease. Hum Genet. 1992;89:365-76.
Burguera JA, Solís P, Salazar A. Estimación de la prevalencia de la enfermedad de Huntington por el método captura-recaptura en la comunidad valenciana. Neurología. 997;25:1845-7.
Deus-Yela J, Pujol J, Espert R. Deterioro neurosicológico en la enfermedad de Huntington. Neurología. 1997;25:1257-68.
Myers RH, Vonsattel JP, Stevens TJ, Cupples LA, Richardson EP, Martin JB, et al. Clinical and Neuropathological assessment of severity in Huntington's disease. Neurology. 1988;38:341-47.
Gusella J, Young AB. Huntington's Disease. En Conneally M, ed. Molecular Basis of Neurology. Boston: Blackwell Scientific Publications. 1993:113-127.
The Huntington`s Disease Research Collaborative Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971-83.
Myers RH, Marans KS, MacDonald ME. Huntington's disease. En Wells RD, ST Warren, eds. Genetic Instabilities and Hereditary Neurological Diseases. California: Academic. 1999:301-23.
Cuenca P, Morales F. Mutaciones inestables: causa de algunas enfermedades neurológicas hereditarias. Acta Méd Costarric. 1999;41:7-15.
Potter NT, Spector EB, Prior TW. Technical Standards and Guidelines for Huntington Disease Testing. Genet Med. 2004;6:61-5.
Schilling G, Sharp A, Loev S, Wagster M, Hua-Li S, Colin O, et al. Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet. 1995;4:1365-71.
Martín-Aparicio E, Lucas JJ. Bases moleculares de la enfermedad de Huntington y posibles mecanismos patogénicos. Neurología.
;35:212-20.
Straus WM. Preparation of genomic DNA from mammalian tissue. En Ausubel FM, Brent R, Kinston RE, eds. Current protocols in molecular biology. New York: Wiley. 1988:2.2.1-2.2.3
Warner JP, Barron LH, Brock DJH. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosome. Mol Cell Probes. 1993;7:23539.
Morera B, Barrantes R, Marín-Rojas R. Gene Admixture in the Costa Rican Population. Ann Hum Genet. 2003;67:71-80.
Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington´s disease. Nat Genet. 1993;4:398403.
Whitefield JE, Williams L, Snow K, Dixon J, Winship I, Stapleton PM, et al. Molecular analysis of the Huntington´s disease gene in New Zealand. N Z Med J. 1996;109:27-30.
Sánchez A, Castellvi-Bel S, Mila M, Genis D, Calopa M, Jiménez D, et al. Huntington´s disease: confirmation of diagnosis and presymptomatic testing in spanish families by genetic analysis. J Neurol Neurosurg Psychiatry. 1996;61:625-7.
Alonso ME, Yescas P, Cisneros B, Martínez C, Silva G, Ochoa A, et al. Analysis of the (CAG)n repeat causing Huntington´s disease in a Mexican population. Clin Genet. 1997;51:225-30.
Lima e Silva T, Guerra H, Bertuzzo C, Lopes I. Molecular diagnosis of Huntington disease in Brazilian patients. Arq Neuropsiquiatr. 2000;58:11-17.
Saleem Q, Roy S, Murgood U, Saxena R, Verma IC, Anand A, et al. Molecular analysis of Huntington´s disease and linked polymorphisms in the Indian population. Acta Neurol Scand. 2003;108:281-86.
Akbas F, Erginel-Unaltuna N. DNA testing for Huntington disease in the Turkish population. Eur Neurol. 2003;50:20-4.
Wexler N, The U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Nat Acad Sci. 2004;101:498-503.
Laccone F, Christian W. A recurrent expansion of a maternal allele with 36 CAG repeats causes Huntington Disease in two sisters. Am J Hum Genet. 2000;66:1145-48.
Kremer B, Almqvist E, Theilmann J, Spence N, Telenius H, Goldberg YP, et al. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet. 1995;57:343-50.
Sánchez A, Mila M, Castellvi-Bel S, Rosich M, Jiménez D, Badenas C, et al. Maternal transmission in sporadic Huntington´s disease. J Neurol Neurosurg Psychiatry. 1997;62:535-7.
Cannella M, Gellera C, Maglione V, Giallonardo P, Cislaghi G, Muglia M, et al. The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet. 2004;125:9298.
Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, et al. Trinucleotide repeat length instability and age of onset in Huntington´s disease. Nat Genet. 1993;4:387-92.
Telenius H, Almqvist E, Kremer B, Spencer N, Squitieri F, Nichol K, et al. Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease. Hum Mol Genet. 1995;4:18995.
Bates GP. The molecular genetics of Huntington disease-a history. Nat Rev Genet. 2005;6:766-73.
Petersén A, Mani K, Brundin P. Recent Advances on the Pathogenesis of Huntington's Disease. Exp Neurol. 1999;157:1-18.
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
